Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
Titel:
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
Auteur:
Fogelman, David R. Holmes, Holly Mohammed, Khalil Katz, Matthew H. G. Prado, Carla M. Lieffers, Jessica Garg, Naveen Varadhachary, Gauri R. Shroff, Rachna Overman, Michael J. Garrett, Christopher Wolff, Robert A. Javle, Milind